ITGAL and cancer: E2 treatment promoted N2 polarization of neutrophils by inducing expression of the lymphocyte function-associated antigen 1 (LFA-1, CD11a/CD18) integrin via elevated transforming growth factor β1 (TGF-β1), leading to cancer cell migration from the primary tumor site to distant organs.